At Pharmapack Europe at Paris Expo, Porte de Versailles, SHL will be featuring Molly 2.25, a high volume auto injector, as well as Molly C, a newly developed product related to connectivity.
Molly 2.25 is SHL’s first high volume auto injector with its design based on the original 1ml Molly. It was created to meet the increasing need for simple delivery of larger doses.
With improved features, the pre-configured device will be attractive to customers who are looking for top-quality products with quick development timelines and reduced costs.
Derived from SHL’s connectivity-based programme, Alubena, for drug delivery, Molly C is a disposable auto injector with a reusable recording unit, which tracks and saves injection data
This concept was created to improve patient adherence, which has been a problem in the healthcare industry. With Molly C, which stands for ‘connected device’, injection data can be better managed and stored with an app that is available for demonstration at the SHL booth.
These two new products are a clear indication that SHL is keeping a focused and innovative approach to advanced drug delivery and developing products that reflect market needs.
Both Molly 2.25 and Molly C will be available for demonstration at the SHL booth in the upcoming Pharmapack event.
For further details, please visit the company at Booth 736 in Hall 5.2.